Form 8-K - Current report:
SEC Accession No. 0001564590-20-026545
Filing Date
2020-05-21
Accepted
2020-05-21 16:05:53
Documents
3
Period of Report
2020-05-21
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xene-8k_20200521.htm 8-K 33048
2 EX-99.1 xene-ex991_6.htm EX-99.1 182073
3 GRAPHIC gukcqretlkim000001.jpg GRAPHIC 7563
  Complete submission text file 0001564590-20-026545.txt   226797
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36687 | Film No.: 20901887
SIC: 2834 Pharmaceutical Preparations